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Background. Parathyroid gland hyperplasia develops in
azotemic patients. A phosphate excess and calcitriol deficiency
play critical roles in its development. Our goals were to deter-
mine whether differences in serum phosphate values at parathy-
roidectomy (PTX) in hemodialysis patients with refractory
hyperparathyroidism: (1) correlated with parathyroid cell pro-
liferation; and (2) affected the antiproliferative response to
in vitro calcitriol. Studies were also performed to determine
whether the phosphate concentration in the medium affected
the antiproliferative response to calcitriol, and whether a high
phosphate diet and calcitriol treatment affected parathyroid cell
proliferation and parathyroid hormone (PTH) levels in normal
rats.
Methods. Forty-seven parathyroid glands from 19 hemodial-
ysis patients were obtained at PTX. Flow cytometry was used to
determine cell proliferation (percent cells in S phase) in excised
parathyroid glands. Similarly, cell proliferation was determined
in parathyroid tissue incubated for 24 hours in medium with
or without 10−7 mol/L calcitriol and with 1 or 4 mmol/L phos-
phate. In normal rats, the effect of 3 days of a high phosphate
diet (1.2% P) and calcitriol treatment (100 pmol/kg) on PTH
values and cell proliferation was evaluated.
Results. In cells from freshly removed parathyroid glands ob-
tained at PTX from hemodialysis patients, there were no sig-
nificant correlations between the percent cells in S phase and
age, gender, and serum phosphate, calcium, and PTH. While
incubation of parathyroid tissue with 10−7 mol/L calcitriol did
reduce cell proliferation (P < 0.001), both the pre-PTX serum
phosphate value (P = 0.003) and female gender (P = 0.003)
were associated with a decreased response to calcitriol. Incu-
bation of parathyroid tissue in medium containing 4 mmol/L
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phosphate did not increase cell proliferation. In normal rats, a
high phosphate diet for 3 days increased cell proliferation (P <
0.05) and PTH levels (P < 0.05), and calcitriol treatment was
without effect.
Conclusion. Our findings suggest a high phosphate burden,
as well as female gender, favor parathyroid cell proliferation
and both may reduce the inhibition of parathyroid function by
calcitriol.
Hyperplasia of the parathyroid gland develops in
azotemic patients as chronic renal failure evolves [1–3]. A
calcitriol deficiency, hypocalcemia, hyperphosphatemia,
and skeletal resistance to parathyroid hormone (PTH)
are major factors in its pathogenesis [4]. Because cal-
citriol decreases PTH synthesis and also inhibits parathy-
roid cell proliferation [5, 6], dialysis patients are treated
with calcitriol to control secondary hyperparathyroidism.
But a significant number of dialysis patients fail to re-
spond to calcitriol treatment [7–9], which may, in part,
be explained by a decrease in vitamin D receptors on
parathyroid cells [10]. But calcitriol treatment also fails
to control hyperparathyroidism in dialysis patients with
hyperphosphatemia [7, 9].
Hyperphosphatemia can increase PTH values by both
a direct effect [11–14] and increasing skeletal resistance to
PTH [15, 16]. High dietary phosphate, even in the absence
of changes in serum calcitriol values, increases parathy-
roid cell proliferation and stimulates development of
parathyroid gland hyperplasia [17, 18]. In azotemic rats,
Dusso et al [19] have shown that a high phosphate diet in-
creases parathyroid cell proliferation by increasing trans-
forming growth factor (TGF)-a. Calcitriol is known to act
on parathyroid cells through specific receptors for cal-
citriol [20] and putatively decreases cell proliferation [6]
by inhibiting c-myc [21], which then results in stimulation
of p21 [22, 23]. Thus, in renal failure, phosphate loading
and/or hyperphosphatemia not only act to increase the
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demand for PTH, but also directly increase parathyroid
cell proliferation.
In the present study, we have evaluated the magnitude
of parathyroid cell proliferation present in freshly excised
hyperplastic parathyroid glands from hemodialysis pa-
tients with refractory hyperparathyroidism. In incubation
studies of these same parathyroid glands, we evaluated
the in vitro capacity of calcitriol to inhibit parathyroid
cell proliferation. Our goal was to determine whether
differences in the serum phosphate concentration at
parathyroidectomy (1) correlated with parathyroid cell
proliferation in freshly excised parathyroid glands, and
(2) affected the known antiproliferative response to in-
cubation with calcitriol. Studies were also performed to
determine (1) the effect of a high phosphate diet on
the inhibition of the parathyroid gland parathyroid cell
proliferation by calcitriol in rats and (2) whether a high
phosphate concentration increases parathyroid cell pro-
liferation in vitro.
METHODS
Freshly excised hyperplastic parathyroid glands from
hemodialysis patients with refractory hyperparathy-
roidism (47 glands from 19 hemodialysis patients) were
studied immediately after parathyroidectomy (PTX).
The mean age and duration of dialysis were 50.3 ±
2.8 years (range, 22 to 75 years) and 77 ± 9 months
(range, 4 to 220 months). Seven patients were male
and 12 were female. None of the patients received cal-
citriol immediately before PTX. Calcitriol was stopped
between 2 weeks and 3 months before PTX, except in 1 or
2 patients in whom the last dose was given between 7
and 14 days before PTX. Because it was not possible to
study normal human parathyroid glands, freshly excised
parathyroid glands from normal dogs were studied. These
parathyroid glands were obtained from euthanized dogs
(ages 2 to 8 years) at the City Animal Control Service.
Incubation conditions. Immediately after resection, a
piece of parathyroid tissue from each gland was main-
tained in culture medium at 4◦C until the experiments
were performed. As previously described, parathyroid
tissue slices of approximately 1 mm3 were used [24,
25]. Five to 10 tissue slices from the same parathyroid
gland were placed in individual wells (24-well dishes from
Nunclon Delta SI, InterMed, Denmark) with constant
shaking at 37◦C in an incubator with a humid atmo-
sphere. The use of 10 tissue slices was done to ensure
that the tissue used in each well was representative of
the whole parathyroid gland, which may contain differ-
ent areas with different growth patterns. The incubation
medium was buffered (pH 7.4) and in mmol/L contained:
NaCl 125, KCl 5.9, MgCl2 0.5, NaH2PO4, and Na2HPO4
1 (1:2 ratio), Na-pyruvate 1, glutamine 4, glucose 12,
and N-(2-hydroxyethyl) piperazine-N′-2-ethanesulfonic
acid (HEPES) 25. Insulin 0.1 IU/mL, bovine serum al-
bumin 0.1%, penicillin G 100 IU/mL, and streptomycin
100 lg/mL were added to the medium. CaCl2 was added
to achieve a final target ionized calcium concentration
of 1.25 mmol/L as measured with a selective electrode
(634 Ca/pH analyzer, Ciba Corning, Essex, UK). The ion-
ized calcium concentration was measured in each well af-
ter the completion of the experiment and confirmed that
the ionized calcium concentration did not change. Cal-
citriol 10−7 mol/L was used in incubation studies because
we previously have shown that this calcitriol concentra-
tion reduced parathyroid cell proliferation in hyperplas-
tic parathyroid glands and lower concentrations failed
to produce inhibition in the same glands [25]. In some
experiments, the phosphate concentration was increased
in the medium by adding sodium phosphate until a con-
centration of 4 mmol/L was achieved. As previously re-
ported, when using a high phosphate concentration in the
medium [11, 24], additional calcium needed to be added
to the medium to maintain the same 1.25 mmol/L target
for ionized calcium concentration.
Parathyroid cell proliferation was assessed by the per-
cent of cells in the S phase of the cell cycle. The cell cycle
was analyzed by flow cytometry as previously described
[26]. Briefly, clean cell nuclei were obtained by the com-
bined action of the nonionic detergent Nonidet-P40 (St.
Louis, MO, USA) and trypsin, followed by treatment with
a trypsin inhibitor (type II-O) to stop the trypsin reaction
and then by RNAase to prevent dye binding to double-
stranded RNA. In a final step, isolated nuclei were stained
with propidium iodide and stabilized with spermine. The
nuclei were acquired by flow cytometry and analyzed
with CELLFIT software (Becton-Dickinson, San Jose,
CA, USA) with doublet discrimination module (DDM)
to discriminate cell agregates. This method measures the
percent of cells in the different phases of the cell cycle:
cells in G0/G1 phase are diploid cells; cells in the S phase
show an increase in DNA synthesis that precedes cell
duplication; and cells in G2+M have doubled the DNA
content or are undergoing mitosis. The percent of cells in
the S phase was used as a marker of cell proliferation.
In vivo experiments in rats. Male Wistar rats weigh-
ing approximately 200 grams were fed either a normal
(0.6%) or high (1.2%) phosphate diet containing 0.6%
calcium. All rats ingested 12 g of diet daily and had
free access to water. Any rat that did not eat all its
food was removed from the study. Half the rats on the
normal and high phosphate diets received 100 pmol/kg
of intraperitoneal calcitriol daily. This dose was cho-
sen because a previous study showed that it did not
increase serum calcium and phosphate values in the
normal rat, but did decrease radiothymidine incorpora-
tion by parathyroid glands [6]. Rats were sacrificed af-
ter 3 days of the experimental diet. Blood was obtained
from the aorta, and parathyroid glands were immediately
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removed free of thyroid for the analysis of parathyroid
cell proliferation.
Reagents. Sodium lauril sarkosinate, proteinase K,
phosphate-buffered saline (PBS), RNAase, Triton X-100,
DNAase free RNAase, propidium iodide, Nonidet-P40,
trypsin, trypsin inhibitor, and spermine were obtained
from Sigma Chemical Company (St. Louis, MO, USA)
and calcitriol from Abbott, Madrid, Spain.
Statistical analysis. Differences between 2 means were
evaluated by the Student t test or the nonparamet-
ric Mann-Whitney test. Comparisons of 3 or more
means were evaluated by one-way analysis of variance
(ANOVA). Linear regression analysis was used to cor-
relate 2 variables, and multiple regression analysis was
used to evaluate the correlation between a dependent
variable with 2 or more independent variables. Analysis
of covariance (ANCOVA) was used to evaluate the ef-
fect of several continuous variables (covariates) and that
of gender (factor) on parathyroid cell proliferation (re-
sponse variable). Results are shown as the mean ± SE.
RESULTS
Serum calcium, phosphate, and PTH values at PTX in
the 19 hemodialysis patients were 10.85 ± 0.27 mg/dL,
6.26 ± 0.28 mg/dL, and 947 ± 121 pg/mL, respectively.
Between the female (N = 12) and male (N = 7) patients,
values were not significantly different: 10.85 ± 0.31 versus
10.86 ± 0.53 mg/dL (serum calcium), 6.13 ± 0.32 versus
6.48 ± 0.53 mg/dL (serum phosphate), and 891 ± 141
versus 1044 ± 232 pg/mL (PTH), respectively.
Hyperplastic parathyroid tissue from hemodialysis pa-
tients. In the freshly excised parathyroid glands (N = 47),
the percent cells in the S phase of the cell cycle, an index
of cell proliferation, was 1.1 ± 0.2%. Possible variables
which may have affected the percent cells in the S phase
were evaluated by multiple regression analysis. Indepen-
dent variables included serum PTH, calcium, and phos-
phate values, age, and gender. Results show that none of
the independent variables were significant.
Incubation studies of parathyroid tissue from hemodial-
ysis patients. Slices of hyperplastic parathyroid tissue from
the 47 parathyroid glands removed from 19 hemodialysis
patients were incubated for 24 hours in a medium contain-
ing a normal phosphate concentration (1 mmol/L) with or
without calcitriol 10−7 mol/L. The percent cells in S phase,
corrected for the initial S phase value by subtracting
the initial from the 24-hour value, was 6.47 ± 0.47%
(−calcitriol) versus 3.31 ± 0.60% (+calcitriol), P < 0.001.
When calcitriol was absent from the medium, the percent
cells in the S phase after 24 hours was similar between fe-
males and males, 6.66 ± 0.82 versus 6.00 ± 1.61%, P =
0.69. While calcitriol in the medium for 24 hours reduced
the percent cells in S phase in both females and males
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Fig. 1. The effect of pre-PTX serum phosphate values on human
parathyroid cell proliferation in vitro. Cell proliferation (% cells in
S phase) was determined in parathyroid tissue from 47 glands (from
19 patients) incubated for 24 hours in medium without (dark bars) or
with (white bars) 10−7 mol/L calcitriol. Groups are divided by the mean
pre-PTX serum phosphate value (6.3 mg/dL). Values for percent cells
in S phase are given as the mean ± SE. ∗P < 0.01 vs. (−calcitriol); #P <
0.05 vs. (+calcitriol) of serum phosphate <6.3 mg/dL.
percent of cells in S phase in males than in females, 4.24 ±
0.80 versus 1.12 ± 0.30%, P < 0.001.
Without calcitriol in the medium, the serum phosphate
value present at PTX had a modest but significant corre-
lation (r = 0.29, P < 0.05) with the percent cells in the
S phase present after a 24-hour incubation. With calcitriol
10−7 mol/L in the medium, the correlation between the
pre-PTX serum phosphate value and the percent cells
in the S phase after a 24-hour incubation increased to
r = 0.42, P = 0.004. The better correlation after incu-
bation with calcitriol occurred at a lower y-intercept as
the regression line was displaced downward without a
change in the slope. Thus, at serum phosphate values of
6 and 8 mg/dL, the percent cells in S phase were 2.5 ±
0.6% (+calcitriol) versus 5.5 ± 1.2% (−calcitriol) at
6 mg/dL, and 5.0 ± 0.8 ±% (+calcitriol) versus 9.0 ±
2.3% (−calcitriol) at 8 mg/dL.
Shown in Figure 1 is the percent cells in the S phase with
and without calcitriol in the medium after the groups were
divided by the mean pre-PTX serum phosphate value
(6.3 mg/dL). In the absence of calcitriol, the percent cells
in the S phase was similar, whether the serum phosphate
value was less or greater than 6.3 mg/dL. But in the pres-
ence of calcitriol, the percent cells in the S phase was
less (P < 0.05) in the group with the lower serum phos-
phate value. Moreover, when serum phosphate was less
than 6.3 mg/dL, incubation with calcitriol reduced (P <
0.01) the percent cells in the S phase. But when the serum
phosphate was greater than 6.3 mg/dL, incubation with
calcitriol did not significantly reduce the percent cells in
the S phase.
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Table 1. An evaluation by multiple regression analysis of potential
factors affecting cell proliferation (percent parathyroid cells in S
phase) during a 24-hour incubation with calcitriol
Incubation for 24 hours Incubation for 24 hours
(+calcitriol) (calcitriol/−calcitriol)a
Multiple regression
Dependent variable—percent cells in S phase
t P t P
Standardized value value Standardized value value
Coefficient Coefficient
Independent variablesb
Serum 0.44 3.21 0.003 0.42 2.92 0.006
phosphate3
Serum 0.03 0.24 0.82 0.13 0.88 0.39
calciumc
Serum 0.06 0.47 0.64 0.02 0.36 0.72
PTHc
Agec −0.07 −0.42 0.67 −0.14 0.73 0.47
Genderc −0.41 −3.11 0.003 −0.33 −2.31 0.025
PTH, parathyroid hormone.
aThe percent cells in S phase when calcitriol 10−7 mol/L was present in the
medium divided by when calcitriol was absent from the medium − overall value
is in percent.
bSerum phosphate, calcium, and PTH values are those present at parathy-
roidectomy.
cSerum phosphate and calcium (mg/dL), PTH (pg/mL), age (years), and gen-
der (female or male).
Multiple regression analysis was used to identify inde-
pendent variables which could have affected the percent
cells in S phase (dependent variable) during the incu-
bation studies. When calcitriol was absent and with age,
gender, and serum values of calcium, phosphate, and PTH
as independent variables, only serum phosphate at PTX
had a marginal effect (P = 0.08). When calcitriol was
present, the percent cells in S phase correlated both with
serum phosphate before PTX (P = 0.003) and gender
(P = 0.003) (Table 1). A similar result was observed when
the dependent variable was the percent cells in S phase
during calcitriol incubation divided by the percent cells
in S phase in the absence of calcitriol. Of the indepen-
dent variables, again only serum phosphate (P = 0.006)
and gender (P = 0.025) were predictors of the response
to calcitriol (Table 1).
ANCOVA was used to better determine the effect of
gender. When calcitriol was absent from the medium, the
percent cells in S phase (response variable) was neither
affected by gender nor by age, the serum calcium, phos-
phorus, and PTH values present at parathyroidectomy.
But as shown in Table 2, when calcitriol was present in
the medium, female gender was associated with a higher
percent of cells in the S phase. A similar effect of female
gender was seen when the percent cells in S phase during
calcitriol incubation was divided by the percent cells in S
phase observed in the absence of calcitriol (Table 2).
In vitro effect of a high phosphate concentration on
parathyroid cell proliferation. To determine whether in
vitro exposure to a high phosphate concentration af-
fected parathyroid cell proliferation and the response
to calcitriol, parathyroid cells from hyperplastic human
Table 2. An evaluation by ANCOVA to determine whether gender
affects cell proliferation (percent parathyroid cells in S phase) during
a 24 hour incubation with calcitriol
B. Incubation
for 24 hours
A. Incubation for 24 hours (+calcitriol) (+calcitriol/−calcitriol)a
ANCOVA
Response variable—percent parathyroid cells in S phase
Covariatesb F ratio P value F ratio P value
X—Serum phosphatec 10.29 0.003 8.11 0.007
X—Serum calciumc 0.04 0.84 0.68 0.42
X—Serum PTHc 0.13 0.72 0.02 0.89
X—Agec 0.30 0.59 0.88 0.35
Factor
A—Genderc 10.10 0.003 5.63 0.02
Effect of genderd Effect of genderd
N S phase (%) N (%)
All 47 2.56 47 57.7
Female 33 4.42 ± 0.62 33 76.9 ± 8.7
Male 14 0.71 ± 0.95 14 38.4 ± 13.3
ANCOVA, analysis of covariance; PTH, parathyroid hormone.
aThe percent cells in S phase when calcitriol 10−7 mol/L calcitriol was present
in the medium divided by when calcitriol was absent from the medium − overall
value is in percent.
bSerum phosphate, calcium, and PTH values are those present at parathy-
roidectomy.
cSerum phosphate and calcium (mg/dL), PTH (pg/mL), age (years), and gen-
der (female or male).
dThe mean S phase values in A and B are not the actual means, but rather are
mean values adjusted for the average value of the covariate.
Table 3. In vitro effect of medium phosphate concentration and
calcitriol on parathyroid cell proliferation (percent cells in S phase) in
parathyroid glands from male hemodialysis patients with severe
secondary hyperparathyroidism and from normal dogsa
Percent cells in S phase
Without Calcitriol
calcitriol (10−7 mol/L)
Human parathyroid gland (N = 11)
Phosphate (1 mmol/L) 5.3 ± 0.3 1.8 ± 0.4b
Phosphate (4 mmol/L) 5.5 ± 0.4 1.9 ± 0.4b
Dog parathyroid gland (N = 12)
Phosphate (1 mmol/L) 7.4 ± 0.9 4.4 ± 1.1c
Phosphate (4 mmol/L) 6.0 ± 1.0 3.4 ± 0.6c
Data given are mean ± SE.
aOnly parathyroid glands from male hemodialysis patients were used because
of the greater calcitriol-induced suppression of parathyroid cell proliferation (per-
cent cells in S phase) in male patients (see Table 2).
b: P < 0.001 vs. without calcitriol; c: P < 0.05 vs. without calcitriol.
(from male patients) and normal dog parathyroid glands
were studied. In both, the percent cells in S phase were
not different after a 24-hour incubation, whether a 1 or
4 mmol/L phosphate concentration was used in the incu-
bation medium (Table 3). In parathyroid cells from hy-
perplastic human and normal dog parathyroid glands, the
presence of calcitriol 10−7 mol/L in the medium decreased
the percent cells in S phase, but again there was not a sig-
nificant difference between a 1 and 4 mmol/L phosphate
concentration.
In vivo effect of high dietary phosphate and calcitriol ad-
ministration on parathyroid cell proliferation in the nor-
mal rat. After 3 days, rats on the high phosphate diet
(HPD) had higher PTH values than rats on the normal
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Table 4. Effect of three days of a high phosphate diet and calcitriol
administration on parathyroid cell proliferation (percent cells in
S phase) and biochemical values in normal rats
HPD + NPD +
HPD calcitriol NPD calcitriol
(N = 22) (N = 19) (N = 22) (N = 18)
Cells in S phase % 1.2 ± 0.2 0.9 ± 0.2 0.7 ± 0.1a 0.6 ± 0.1b
Ionized calcium 1.24 ± 0.05 1.24 ± 0.05 1.26 ± 0.02 1.27 ± 0.03
mmol/L
(N = 11) (N = 12) (N = 12) (N = 11)
Phosphate mg/dL 9.3 ± 0.6 9.7 ± 0.7 9.0 ± 0.5 9.5 ± 0.5
PTH pg/mL 41 ± 8 51 ± 10 23 ± 6a 8 ± 4bc
Data given are mean ± SE. PTH, parathyroid hormone. HPD, high phosphate
diet (1.2% P, 0.6% Ca); NPD, normal phosphate diet (0.6% P, 0.6% Ca).
aP < 0.05 vs. HPD; bP < 0.05 vs. HPD + calcitriol; cP < 0.05 vs. NPD.
phosphate diet (NPD) (Table 4). The increase in PTH
values in the HPD group was associated with an increase
in the percent of parathyroid cells in S phase. Ionized
calcium and serum phosphate values were not different
between the HPD and NPD groups. Calcitriol adminis-
tration decreased (P < 0.05) PTH values in rats on a NPD
(NPD + calcitriol), but not in rats on a HPD (HPD + cal-
citriol). As compared to its control on a HPD and on a
NPD, calcitriol administration did not decrease the per-
cent cells in S phase. Similar to the difference observed
between rats on a HPD and NPD, the percent cells in
S phase was greater (P < 0.05) in the HPD + calcitriol
group than in the NPD + calcitriol group. Ionized cal-
cium and serum phosphate values were unchanged by
the administration of calcitriol.
DISCUSSION
We evaluated whether factors present at PTX cor-
related with the degree of cell proliferation in freshly
excised, hyperplastic parathyroid glands. Along with
marked elevations in PTH values, hemodialysis patients
had hypercalcemia and hyperphosphatemia. Our initial
expectation was that the degree of cell proliferation might
be affected by the magnitude of hyperparathyroidism, the
degree of hyperphosphatemia, or differences in the serum
calcium concentration. However, none of these had a sig-
nificant effect.
In a previous study of freshly excised parathyroid
glands from hemodialysis patients with refractory hyper-
parathyroidism, we showed that calcitriol 10−7 mol/L in
the medium reduced parathyroid cell proliferation dur-
ing a 24-hour incubation [25]. The present results confirm
those findings, but more interesting was that when cal-
citriol was added to the medium, a high serum phosphate
value before PTX adversely affected the response to cal-
citriol. One possibility is that a high serum phosphate
concentration imprints the parathyroid cell with signals
that can be detected during the subsequent 24 hours of
in vitro incubation and counteracts the suppressive effect
of calcitriol.
In incubation studies of parathyroid glands excised
from normal dogs and from hemodialysis patients, we
showed that increasing the phosphate concentration
in the medium from 1 to 4 mmol/L did not increase
the percent cells in S phase nor alter the response to
calcitriol. These results suggest that imprinting of the
signal for parathyroid growth may require more than
24 hours of exposure to a high phosphate concentration
or such imprinting can only occur in vivo. The expression
of cyclin-dependent kinase inhibitor p21/WAF and the
growth promoter TGF-a has been shown to change in
relation to dietary phosphate [19]. Support for our find-
ings about the effect of phosphate also comes from a re-
cent in vitro study in which, as in our study, parathyroid
cells were cultured from parathyroid glands of patients
with secondary hyperparathyroidism [27]. In that study,
a high phosphate concentration in the medium increased
parathyroid cell proliferation after a long incubation
period.
Our results in normal rats and those of others in
azotemic rats [17, 18] suggest that dietary phosphate load-
ing can rapidly increase the rate of parathyroid cell pro-
liferation. Moreover, a high phosphate diet was shown
to increase parathyroid cell proliferation in azotemic rats
by day 2, even before any decrease in the calcium sensing
receptor [28]. In our normal rats on a high phosphate
diet, ionized calcium and serum phosphate values ob-
tained after 3 days were not different from those in rats
on a normal phosphate diet. Even after only 3 days, in-
creased PTH values were accompanied by an increase
in parathyroid cell proliferation. Moreover, a calcitriol
dose, which was previously shown to decrease (1) radio-
thymidine incorporation by parathyroid glands of normal
and uremic rats [6], and (2) PTH mRNA levels in normal
and uremic rats [29], did not significantly reduce PTH
values and parathyroid cell proliferation in normal rats
on a high phosphate diet. Consequently, our data sug-
gest that dietary phosphate loading not only stimulates
PTH secretion, but also induces resistance to the PTH
lowering and antiproliferative effects of calcitriol. These
results are in agreement with clinical studies showing that
calcitriol fails to control secondary hyperparathyroidism
in patients with high serum phosphate levels [7–9].
Our study results do not suggest a specific mecha-
nism(s) by which a high phosphate diet increases parathy-
roid cell proliferation. But Dusso et al [19] reported that
a high phosphate diet promoted parathyroid cell prolif-
eration by stimulation of TGF-a. Thus, it is possible that
the stimulation of TGF-a may be important for the im-
printing process induced by phosphate.
Because of the known association between the devel-
opment of primary hyperparathyroidism and female gen-
der [30, 31, 32], previous studies have evaluated whether
female gender is associated with more severe secondary
hyperparathyroidism in renal failure. Many of these
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studies have reported an association between female gen-
der and the magnitude of hyperparathyroidism, the need
for parathyroidectomy, the failure to respond to treat-
ment for hyperparathyroidism, or other surrogates of hy-
perparathyroidism, such as renal osteodystrophy [7, 33–
40]. Our own recent experience also supports the associ-
ation between female gender and the need for parathy-
roidectomy. Since 1995, we have received parathyroid
glands for study from 119 different dialysis patients or
renal transplant recipients from several medical centers
throughout Spain. Of these 119 patients with refractory
secondary hyperparathyroidism, 77 were female and only
42 were male (P < 0.001). Thus, it would seem that just
as in primary hyperparathyroidism, female gender is im-
portant in the development of secondary hyperparathy-
roidism. While estrogen has been reported to directly in-
crease PTH gene expression and PTH secretion [41, 42],
it has also been suggested that the effect of estrogen could
be indirect (e.g., via calcium metabolism) [43]. But if the
effect were indirect and estrogen the causal agent, the dif-
ference between female and male patients we observed
in our ex vivo studies of freshly harvested parathyroid
cells would not be expected. Thus, our results provide
experimental evidence indicating that differences in gen-
der may affect the PTH response to calcitriol treatment.
While we cannot directly attribute this effect to estrogen,
it should be considered a likely candidate.
CONCLUSION
Our in vitro results in parathyroid tissue freshly har-
vested from hemodialysis patients with refractory hyper-
parathyroidism showed that both female gender and a
high serum phosphate value before PTX reduced the an-
tiproliferative effect of calcitriol on cell proliferation. The
effect of a high serum phosphate value could not be du-
plicated by incubation of the parathyroid tissue in a high
phosphate medium. In normal rats, a high phosphate diet
stimulated parathyroid cell proliferation and prevented
the PTH lowering and the antiproliferative effects of cal-
citriol administration. In conclusion, our findings suggest
a high phosphate burden, as well as female gender, favor
parathyroid cell proliferation, and both may reduce the
inhibition of parathyroid cell proliferation by calcitriol.
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